| 001 | 295896 | ||
| 005 | 20241217120828.0 | ||
| 037 | _ | _ | |a DKFZ-2024-02710 |
| 100 | 1 | _ | |a Roth, Lia Theresia |0 P:(DE-He78)b0cd6fa24eff7ff5451a6a7351787eb3 |b 0 |u dkfz |g female |
| 245 | _ | _ | |a Therapeutic human Papillomavirus 16 Vaccination – in vitro – Characterization and Subsequent Validation in a Major Histocompatibility Complex-Humanized Murine Model. |
| 260 | _ | _ | |c 2024 |
| 336 | 7 | _ | |a Output Types/Dissertation |2 DataCite |
| 336 | 7 | _ | |a DISSERTATION |2 ORCID |
| 336 | 7 | _ | |a PHDTHESIS |2 BibTeX |
| 336 | 7 | _ | |a Thesis |0 2 |2 EndNote |
| 336 | 7 | _ | |a Dissertation / PhD Thesis |b phd |m phd |0 PUB:(DE-HGF)11 |s 1734422978_26098 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a doctoralThesis |2 DRIVER |
| 502 | _ | _ | |a Dissertation, Universität Heidelberg, 2024 |c Universität Heidelberg |b Dissertation |d 2024 |g Medizinische Fakultät Heidelberg |o 2024-09-11 |
| 536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:295896 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)b0cd6fa24eff7ff5451a6a7351787eb3 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
| 914 | 1 | _ | |y 2024 |
| 920 | 1 | _ | |0 I:(DE-He78)D410-20160331 |k D410 |l Immuntherapie und -prävention |x 0 |
| 980 | _ | _ | |a phd |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)D410-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::